Biosketch

Jeff J. Guo, B.Pharm., Ph.D.

Jeff J. Guo, PhD, is an Associate Professor of Pharmacoepidemiology and Pharmacoeconomics at the University of Cincinnati (UC) College of Pharmacy and a Research Fellow of the Institute for the Health Policy and Health Services Research at the UC Medical Center.  He has been teaching graduate courses, Pharmaceutical Economics & Policy, Pharmacovigilance, Research in Pharmacoepidemiology & Drug Safety and Biostatistics for Pharmacist at UC, and has served as major advisor for several PhD, MS, and PharmD students. 
Prior to joining UC, he worked as a Drug Information Specialist at the United States Pharmacopeia in Rockville, Maryland; as a research manager of pharmacoepidemiology & pharmacoeconomics at the Degge Group, in Arlington, Virginia; and as a project manager at the China National Drug Administration and the China National Economic & Planning Commission. 
He is a founder and the current Chair for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Asian Consortium Advisory Committee.  He has extensive project experience with Ohio and Alabama state Medicaid drug utilization reviews and health policy research, Pharmacopeia Drug Information, and the national medication error report system (MedMARx®).  He has had contract research experience with major pharmaceutical companies such as Bristol-Myers Squibb, Johnson & Johnson, AstraZeneca, and Pfizer.  He has numerous peer-reviewed publications in pharmacoepidemiology and pharmacoeconomics on topics including drug utilization review in Medicaid, physician prescribing behavior, diabetes associated with antipsychotics, cisapride and contraindicated medications, acute pancreatitis associated with antiretroviral medications, drug-induced hepatotoxicity, cost-of-illness analysis for diabetes, a cost-benefit analysis for asthmatic medications, the measurement of quality in the practice of oncology, the costs to business of HIV/AIDS, drug control policy, drug price, pharmaceutical market competition, as well as an evaluation of health outcomes for children and adolescences.